WHO-GMP sourced EU-GMP partners ISO 9001:2015 49+ export markets Since 2003

Atazanavir (Reyataz) is an HIV-1 protease inhibitor taken once daily with food, given on its US label with ritonavir 100 mg in the recommended regimen for treatment-naive and treatment-experienced adults, and stored at controlled room temperature.

M Care Exports supplies atazanavir, including the originator Reyataz, Indian-made atazanavir 300 mg and Indian-made atazanavir 300 mg + ritonavir 100 mg tablets, to hospital pharmacies, licensed importers, distributors and tender authorities internationally, with established supply lanes into the GCC, Africa and Europe. If you are looking for atazanavir for an HIV programme, send the destination, the presentation and the quantity. Each destination has its own registration route and import licence, and we quote per destination.

WhatsApp an atazanavir enquiry → Send enquiry by form
WHO-GMP sourcing CDSCO licensed exporter EU-GMP capable partners Cold-chain validated (2–8°C & −25°C) CTD / eCTD dossier-ready ISO 9001:2015
Bulk supply and export terms

Atazanavir exporter and bulk supplier from India.

"We need a partner for atazanavir" is a typical enquiry from a hospital pharmacy or an HIV programme tender desk. M Care is a merchant-exporter: we quote against your specification and confirm which line your destination accepts. The first question is the presentation, because atazanavir reaches buyers in more than one form. The originator Reyataz is a capsule (the US label lists 200 mg and 300 mg capsules and a 50 mg oral powder packet, and the EMA page lists capsules of 100, 150, 200 and 300 mg and the 50 mg oral powder). Our Indian-made lines include atazanavir 300 mg (Atazor) and atazanavir 300 mg + ritonavir 100 mg tablets (Synthivan, Virataz). We supply both originator or regulator-registered brands and Indian-made lines, and we do not claim the Indian brands are registered in any destination. The landed price turns on the line chosen, the pack, the quantity, the registration route in the destination and Incoterms. The US label stores Reyataz capsules at controlled room temperature, so freight is planned without refrigerated packing.

Source

WHO-GMP-certified Indian manufacturing line, named on every quote.

Minimum order

No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.

Pricing

On request. Indicative FOB or CIF quote, formal proforma on confirmation.

Incoterms

EXW, FOB, CIF, CIP or DAP.

Payment

Letter of credit (sight or usance) and telegraphic transfer.

Documentation

WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.

Shelf-life

Minimum remaining shelf-life agreed per order and confirmed on the proforma.

Response

Availability and CoPP status within two working days; pre-alert documents before dispatch.

Request a bulk quote → Send a bulk enquiry by form How bulk supply works
At a glance

HIV-1 protease inhibitor, sourced and documented for export.

Atazanavir is an HIV-1 protease inhibitor. The US label for Reyataz (DailyMed page revised December 2024, E.R. Squibb & Sons, L.L.C.) lists it in combination with other antiretroviral agents for HIV-1 infection in adults and in paediatric patients 3 months and older weighing at least 5 kg. Dosage forms are 200 mg and 300 mg capsules and a 50 mg oral powder packet. The recommended adult regimen on that label is 300 mg once daily with ritonavir 100 mg, with food, for treatment-naive and treatment-experienced adults. For treatment-naive adults unable to tolerate ritonavir, the label gives 400 mg once daily, and for treatment-experienced adults use without ritonavir is not recommended. The EMA page lists the marketing authorisation holder as Bristol-Myers Squibb Pharma EEIG and describes Reyataz as used together with low-dose ritonavir and other antiviral medicines in adults and children aged 3 months and over and weighing at least 5 kg. The WHO Model List of Essential Medicines (2023) lists atazanavir + ritonavir as a heat stable tablet of 300 mg (as sulfate) + 100 mg, under protease inhibitors.

Active ingredient

Atazanavir (as sulfate). HIV-1 protease inhibitor.

Forms and strengths

200 mg capsule (US Reyataz label); 300 mg capsule (US Reyataz label); 50 mg oral powder packet (US Reyataz label); 300 mg atazanavir (Indian-made line, Atazor); 300/100 mg atazanavir + ritonavir tablet (Indian-made line).

Indications

Atazanavir (Reyataz) is an HIV-1 protease inhibitor taken once daily with food; its US label gives ritonavir 100 mg in the recommended adult regimen.

Administration

Oral. Capsule, oral powder and tablet.

Documentation

Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.

Who we supply

Hospital pharmacies, licensed importers and tender desks across our export markets.

India is our origin. We do not sell into the Indian market.

Buyers are hospital pharmacists and HIV programme pharmacies, MoH and hospital tender desks, and licensed importers and distributors internationally. Typical enquiries read "I'm looking for atazanavir 300 mg + ritonavir 100 mg tablets for a tender" or "We need a partner for Reyataz capsules". Each destination has its own route to registration or import, for example the Emirates Drug Establishment (EDE) in the UAE, NAFDAC in Nigeria and the MHRA in the UK, and we align the offer with it before quoting. Whether a given atazanavir line is registered, or needs a named-patient or unlicensed import, depends on the destination regulator, and M Care Exports confirms the route per enquiry.

GCC registration routes

Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.

MoH registration, GCC →

UK unlicensed routes

Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.

MHRA Specials →

Tender desks

Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.

Tender response →

Dossier support

CTD documentation from the sourcing manufacturer, compiled for your regulator's format.

Dossier preparation →

Pharmacist's note

What the dispensing pharmacist checks on atazanavir.

Start with the regimen, because the pack list follows it. The US label gives 300 mg atazanavir once daily with ritonavir 100 mg, with food, as the recommended regimen for both treatment-naive and treatment-experienced adults. Its Table 1 lists 400 mg once daily without ritonavir for treatment-naive adults unable to tolerate ritonavir, and the label does not recommend use without ritonavir in treatment-experienced adults. Capsules and oral powder must be taken with food, and the US label says not to open the capsules. The WHO Model List of Essential Medicines notes that ritonavir is recommended for use in combination as a pharmacological booster, and not as an antiretroviral in its own right. The US label warns that PR interval prolongation may occur, with ECG monitoring to be considered in patients with pre-existing conduction system disease. It also describes hyperbilirubinaemia, nephrolithiasis and cholelithiasis, and chronic kidney disease. It contraindicates coadministration with strong CYP3A inducers, and Table 6 lists named contraindicated drugs, so screen the patient's co-medication. The oral powder contains phenylalanine. Storage for the capsules is 25 °C with excursions permitted to 15 to 30 °C, and for the oral powder 20 to 30 °C.

Regulatory & quality

The documentation pack a regulator actually asks for.

Reyataz is stored at controlled room temperature on its US label: capsules at 25 °C with excursions permitted to 15 to 30 °C, and the oral powder at 20 to 30 °C. Storage for the Indian-made lines is as printed on the manufacturer's label, which we confirm per line before quoting. Atazanavir has an originator and other regulator-authorised versions in the US, EU and UK: the US label for Reyataz is held by E.R. Squibb & Sons, L.L.C., and the EU authorisation by Bristol-Myers Squibb Pharma EEIG. The EMA describes Atazanavir Viatris (previously Atazanavir Mylan, held by Viatris Limited) as a generic medicine whose reference medicine is Reyataz, and Atazanavir Krka as a generic medicine of Reyataz whose authorisation was withdrawn on 23 February 2026 at the holder's request. In the UK, the emc lists Atazanavir Sandoz 300 mg hard capsules from Sandoz Limited. M Care documentation covers batch certificates of analysis, export documents and destination-aligned dossier support where the regulator asks for it. India's CoPP, WHO-GMP certificate and manufacturing licence are issued by the State Licensing Authority, and a CoPP is valid for the period its issuer prints on it. We are a merchant-exporter and not a manufacturer, and we state the source and status of each line before quoting.

CoA and MoA, per batch

Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.

CoPP, WHO-GMP, MFG licence

Certificate of pharmaceutical product, site GMP certificate and manufacturing licence, issued by the state drug regulator and naming the actual manufacturing site.

CTD Module 3

Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.

Pack insert, labels, artwork

Destination-language patient information and labelling to the local regulator's standard, locked before shipment.

Pharmacovigilance

A named PV contact arranged in the destination market where the registration requires one.

How the enquiry works

Molecule · strength · volume · destination. One working day to a quote.

  1. Send us the specifics. Form and strength, pack preference, destination market and indicative volume for atazanavir.
  2. We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
  3. Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
  4. Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
  5. After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Frequently asked

Atazanavir supply, the specific questions.

Is there a generic of Reyataz, and what is the Reyataz generic name?

The generic (non-proprietary) name is atazanavir, and the active ingredient is atazanavir sulfate. DailyMed lists atazanavir capsule labels under non-brand names from Camber Pharmaceuticals, Laurus Labs, Aurobindo Pharma and Teva Pharmaceuticals USA, alongside Reyataz from E.R. Squibb & Sons. The EMA describes Atazanavir Viatris as a generic medicine with Reyataz as its reference medicine. Its page for Atazanavir Krka calls it a generic medicine of Reyataz, shows that authorisation as withdrawn on 23 February 2026, and states that other generic medicinal products of Reyataz are authorised and marketed in the EU. The UK emc lists Atazanavir Sandoz 300 mg hard capsules. M Care Exports also supplies Indian-made atazanavir lines and confirms the line and its status per destination.

What decides the Reyataz cost for an importer?

We do not publish prices. The landed cost depends on whether you want the originator Reyataz, a regulator-registered version or an Indian-made line, the presentation (capsule, oral powder or tablet), the strength, the pack size, the quantity, the registration route in your destination and Incoterms. The US label stores Reyataz at controlled room temperature, which shapes the freight plan. M Care Exports quotes per destination once you send the line, strength, quantity and country.

Reyataz generic name: is it the same as atazanavir 300 mg + ritonavir 100 mg?

Atazanavir is the generic name of the active substance in Reyataz. Atazanavir 300 mg + ritonavir 100 mg is a combination of atazanavir (as sulfate) with ritonavir, and the WHO Model List 2023 lists a heat stable tablet of that strength combination. Reyataz itself contains atazanavir alone, and its US label gives ritonavir 100 mg alongside it in several regimens. Our catalogue carries Indian-made atazanavir + ritonavir tablets under names such as Synthivan and Virataz, and atazanavir 300 mg under the name Atazor. These are named as Indian-made lines, and we do not say they are registered in any destination.

How is atazanavir taken, and when is ritonavir used?

The US label for Reyataz gives 300 mg once daily with ritonavir 100 mg, with food, as the recommended regimen for treatment-naive and treatment-experienced adults. For treatment-naive adults unable to tolerate ritonavir, it gives 400 mg once daily, and it does not recommend use without ritonavir in treatment-experienced adults. The UK SmPC for Atazanavir Sandoz capsules on emc states 300 mg once daily taken with ritonavir 100 mg once daily and with food. Always follow the label of your destination.

Does atazanavir need a cold chain?

The US label for Reyataz gives controlled room temperature storage: capsules at 25 °C with excursions permitted to 15 to 30 °C, and the oral powder at 20 to 30 °C. The UK SmPC for Atazanavir Sandoz capsules states do not store above 30 °C. Storage for Indian-made lines follows the manufacturer's label, which we confirm per line. Heat stable is also how the WHO Model List 2023 describes the atazanavir + ritonavir tablet.

How does an importer buy atazanavir for an HIV programme tender?

The route depends on the destination regulator. In the UAE, registration is with the Emirates Drug Establishment, and other countries have their own regulator, so a registered brand and an Indian-made line may be treated differently. M Care Exports supplies hospitals, licensed importers and tender authorities internationally, and confirms the registration or import route per enquiry. Send the presentation, strength, quantity and destination, and we state which originator, regulator-registered or Indian-made line fits. See the antivirals range for related lines.

Sources and review

Who stands behind this page, and where its statements come from.

Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-11-15.

This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.

Atazanavir enquiry

Send the specifics. You'll have a price inside one working day.

Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.

WhatsApp the Mumbai desk → Enquiry form Back to antivirals & hiv